Jorkasky joins Tengion’s board of directors

Tuesday, August 16, 2011 02:23 PM

Tengion has named Diane Jorkasky, M.D. to its board of directors. Jorkasky recently joined Endo Pharmaceuticals as senior vice president, clinical development and chief medical officer. She was previously chief development and medical officer at Aileron Therapeutics.

"We are pleased to welcome Diane to the Board and look forward to tapping into her extensive clinical development experience as we move our product candidates forward," said David Scheer, chairman of the Tengion board of directors.

Tengion also announced today that Brenda Gavin, D.V.M., managing partner at Quaker BioVentures, is stepping down from the Tengion board of directors after five years of service.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs